Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Ustekinumab

NHS Wales Shared Services Partnership-Procurement Services

This public procurement record has 4 releases in its history.

Award

11 Aug 2026 at 11:54

UK7 - Contract Details Notice
Award

15 Jun 2026 at 12:29

UK6 - Contract Award Notice
Tender

02 Feb 2026 at 15:51

UK4 - Tender Notice
Planning

15 Dec 2025 at 15:44

UK2 - Preliminary Market Engagement Notice
Summary of the contracting process

NHS Wales Shared Services Partnership Procurement Services, hosted by Velindre University NHS Trust, procured the supply of ustekinumab pharmaceutical products for All Wales Health Boards and Trusts. The requirement covers delivery across Wales and is categorised as goods, specifically medicines for health service use. The named buyer is based in Cardiff. The procurement concerns a single supply requirement rather than construction, consultancy or a wider clinical service. Businesses relevant to this opportunity are pharmaceutical manufacturers, marketing authorisation holders, wholesalers or specialist medicines suppliers able to provide ustekinumab for NHS use and support distribution across the Welsh health service. The requirement is suitable for small and medium-sized enterprises, although all awarded suppliers are large organisations.

The procurement is complete and has been awarded, with an active contract signed on 7 August 2026. NHS Wales used an open procedure, with six bids received and six reaching the final stage. The award was made on 4 June 2026 to Amgen Ltd, Fresenius Kabi Ltd, Celltrion Healthcare, Gedeon Richter, Sandoz Ltd and Thornton & Ross. The award and contract value is £6,532,462.75 excluding VAT, or £7,838,955.30 including VAT. The contract runs from 1 October 2026 to 30 June 2028, with an option to extend by up to 12 months, to 30 June 2029. Bids closed on 9 March 2026, enquiries closed on 6 March 2026, and the award period ended on 10 June 2026. Evaluation ranked product quality and acceptability first, overall contract cost second, and environmental, social value and community benefits third.

This award demonstrates substantial NHS Wales demand for ustekinumab supplied through an open, multi-supplier pharmaceutical procurement. A credible future competitor would need dependable access to the medicine, the regulatory and quality systems required to supply it lawfully, and the manufacturing or distribution capacity to support health boards and trusts across Wales. The evaluation shows that product quality and acceptability were more important than overall contract cost, while environmental performance, social value and community benefits also formed part of the assessment. Suppliers should therefore be able to evidence consistent product quality, resilient fulfilment, reliable medicines logistics and a clear contribution to wider community or environmental objectives. The six final-stage bids indicate competition from established large pharmaceutical businesses, while the requirement was also identified as suitable for SMEs.

How relevant is this notice?

Notice Information

Notice Title

Ustekinumab

Notice Description

Contract award details for the supply of Ustekinumab

Planning Information

This notice is being issued to advise suppliers of a forthcoming opportunity that is due to be published by Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts). There is no formal engagement process for this opportunity. Any suppliers who may like more information on this opportunity before the tender is published, please contact Caroline Cheng (Caroline.Cheng2@wales.nhs.uk)

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-05f601
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/076159-2026
Current Stage
Award
All Stages
Planning, Tender, Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£9,489,301 £1M-£10M
Lots Value
£9,489,301 £1M-£10M
Awards Value
£6,532,462 £1M-£10M
Contracts Value
£6,532,462 £1M-£10M

Notice Dates

Publication Date
11 Aug 20261 months ago
Submission Deadline
9 Mar 2026Expired
Future Notice Date
2 Feb 2026Expired
Award Date
4 Jun 20263 months ago
Contract Period
1 Oct 2026 - 30 Jun 2028 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS Wales Shared Services Partnership-Procurement Services
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
CARDIFF
Postcode
CF14 3UZ
Postcode Area
Cardiff
Country
Wales
Major Region (ITL 1)
TLL Wales
Basic Region (ITL 2)
TLL5 South East Wales
Small Region (ITL 3)
TLL52 Cardiff and Vale of Glamorgan
Delivery Location
TLL Wales
Local Authority
Cardiff
Electoral Ward
Gabalfa
Westminster Constituency
Cardiff North

Supplier Information

Number of Suppliers
6
Supplier Names

Amgen Ltd

Fresenius Kabi Limited

Celltrion Healthcare United Kingdom Limited

Gedeon Richter UK Ltd

Sandoz Ltd

Thornton and Ross Ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...